F11R and cancer: A recent report describes that the antibiotic against Gram-positive bacteria Tetrocarcin-A, that was noted for the induction of apoptosis in cancer cells [51], can be a potential novel drug for TNBC treatment due to its antagonistic properties towards F11R/JAM-A [13].